WH
NTRP

William Harnisch’s Neurotrope, Inc. Common NTRP Stock Holding History

William Harnisch’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,000
Closed -$191K – 63
2017
Q1 		$191K Buy
+10,000
New +$189K 0.02% 43

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

William Harnisch's NTRP Position: Q2 2017 in Review

William Harnisch sold out of Neurotrope, Inc. Common (NTRP) in Q2 2017, closing a stake of 10,000 shares — an estimated $191K sold.

William Harnisch first reported a position in NTRP in Q1 2017 and held it in 1 quarter. The position peaked at $191K in Q1 2017. 27 funds tracked by Wall St. Rank hold NTRP as of Q2 2017.

  • William Harnisch reported no remaining Neurotrope, Inc. Common position as of Q2 2017 after selling out during the quarter.
  • William Harnisch sold 10,000 Neurotrope, Inc. Common shares in Q2 2017, an estimated $191K.
  • William Harnisch first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 1 quarter.
  • William Harnisch's Neurotrope, Inc. Common position peaked at $191K in Q1 2017.
  • 27 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q2 2017.

Based on Peconic Partners's 13F filing for Q2 2017, filed 14 Aug 2017.